Geode Capital Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,494
Closed -$87.9K 4582
2025
Q4
$87.9K Buy
40,494
+8,344
+26% +$33.9K ﹤0.01% 4125
2025
Q3
$177K Sell
32,150
-284
-0.9% -$2.17K ﹤0.01% 3964
2025
Q2
$243K Buy
32,434
+631
+2% +$4.58K ﹤0.01% 3808
2025
Q1
$209K Buy
31,803
+1,004
+3% +$11.9K ﹤0.01% 3837
2024
Q4
$405K Buy
30,799
+2,336
+8% +$24K ﹤0.01% 3673
2024
Q3
$162K Buy
28,463
+2,090
+8% +$13.9K ﹤0.01% 3977
2024
Q2
$155K Sell
26,373
-36,494
-58% -$327K ﹤0.01% 4000
2024
Q1
$569K Buy
62,867
+17,233
+38% +$206K ﹤0.01% 3565
2023
Q4
$502K Buy
45,634
+698
+2% +$7.78K ﹤0.01% 3607
2023
Q3
$796K Buy
44,936
+10,879
+32% +$396K ﹤0.01% 3419
2023
Q2
$1.87M Buy
34,057
+4,757
+16% +$303K ﹤0.01% 3131
2023
Q1
$2M Buy
29,300
+1,477
+5% +$115K ﹤0.01% 3029
2022
Q4
$1.69M Buy
27,823
+1,603
+6% +$149K ﹤0.01% 3120
2022
Q3
$2.63M Sell
26,220
-1,961
-7% -$228K ﹤0.01% 2988
2022
Q2
$2.48M Buy
28,181
+14,973
+113% +$1.83M ﹤0.01% 3039
2022
Q1
$2M Sell
13,208
-508
-4% -$94.5K ﹤0.01% 3256
2021
Q4
$4.37M Buy
+13,716
New +$4.84M ﹤0.01% 2969

Other funds holding RBOT

Geode Capital Management's RBOT Position: Q1 2026 in Review

Geode Capital Management sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 40,494 shares — an estimated $87.9K sold.

Geode Capital Management first reported a position in RBOT in Q4 2021 and held it in 17 quarters. The position peaked at $4.37M in Q4 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Geode Capital Management reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 40,494 Vicarious Surgical shares in Q1 2026, an estimated $87.9K.
  • Geode Capital Management first reported a position in Vicarious Surgical in Q4 2021 and held it in 17 quarters.
  • Geode Capital Management's Vicarious Surgical position peaked at $4.37M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.